The Patent Finder

Biotheus Inc.

5 patents currently held · Updated Nov 21, 2026
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded as renamed to BioNTech (Zhuhai) Pharmaceuticals R&D Co., Ltd. (2026)

0
Ending by 2030
Aug 2042
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 21, 2027.

Recent changes

  • 2 of the patents on this record were granted since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 5 of 5

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 12,583,933ANTI-CD73 Antibody and Use Thereof
In force
 · High confidence
In forceHigh confidence
US 12,774,340ANTI-4-1BB Single-Domain Antibodies, Nanobodies, Fusion Proteins Thereof and Methods of Use Thereof for Treatment
In force
 · High confidence
In forceHigh confidence
US 12,774,346Anti-CEACAM5 monoclonal antibody and preparation method thereof and use thereof
In force
 · High confidence
In forceHigh confidence
US 12,600,782ANTI-PD-L1 and PD-L2 Antibody and Derivatives and Use Thereof
In force
 · High confidence
In forceHigh confidence
US 12,565,534Nano-Antibody Targeting Caix Antigen and Application Thereof
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 5: 2 patents in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

12 pending · 2 no status recorded

Showing 1 to 10 of 14, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/273,605ANTI-PD-L1 Single-Domain Antibody and Derivatives and Use ThereofJul 18, 2025Pending
19/205,772ANTI-VEGF-ANTI-PD-L1 Bispecific Antibody, Pharmaceutical Composition of Same, and Uses ThereofMay 12, 2025Pending
18/853,160ANTI-PD-1 Monoclonal Antibody, Derivative Thereof and Use ThereofMar 31, 2023Pending
18/853,158ANTI-CD39 Nanobody and Uses ThereofMar 31, 2023Pending
18/852,935Anti-Tigit-Anti-Pvrig Bispecific Antibody, Pharmaceutical Composition Thereof and Use ThereofMar 31, 2023Pending
18/852,907Anti-Pvrig Antibody, Pharmaceutical Composition Thereof and Use ThereofMar 31, 2023Pending
18/852,902Mar 31, 2023No status recorded
18/852,602Monoclonal Antibodies and Bispecific Antibody Against C-MetMar 31, 2023Pending
18/711,482Bispecific Antibody against TIGIT and PD-L1, and Pharmaceutical Composition Thereof and Use ThereofNov 17, 2022Pending
18/702,317Anti-Mesothelin Nanobodies and Use ThereofOct 13, 2022Pending
10 of 14 applications shown.
Pro members see all 14 published applications.
Pro members: see all 14 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited